3. saves 30% in drug production costsusing PDG technology
4. Market opportunity Customers: pharmaceutical companies - originators and generics: Formulation & Life cycle management department Production department Under pressure: little new products, generic competition and cost pressure by health authorities Market: development and production of tablets ($48.4B, +5%) Targeted market: new tablets ($1.2B) Very big market – 300 new products every year Competition: contract manufacturers (i.e. Patheon, Catalent, Aenova) Production system providers (i.e. Alexanderwerk, Hosakawa, Fitzpatrick) PDG Technology is unique (no base inventions since 20 years) It solves development problems, speed-to-market issues and is cost effective Market share target: 5% in 2015 Market share is only limited by development speed of capacity (investment)
35. No registration dossier changes needed (new product with new registration)*= average Gx product sales: $150M, today’s production costs: $22M (15% of sales), 25% saved: $5.6M
58. Management Team Steffen Mittwich - CEO 20 yrs of pharmaceutical experience (Pfizer, Novartis, Sanofi-Aventis) Launched Winthrop Generics (start-up) as CEO in Switzerland, grew from $0 to $6M in 2 yrs Group Product Manager at Pfizer – brought Alzheimer’s product to market, grew from $0 to $75M in 3 yrs; responsible for $210M total in revenue from 1998 to 2001 Dr. Rob Lammens - CTO 30 yrs of pharmaceutical development and production experience at Bayer; expert in oral solid dosage forms and dry granulation / roller compaction Improved scale-up from lab to production by creating a new system to determine process upgrade parameters saving approx. $1.3M development cost / product = $20M savings (15 products) Developed leading roller compactor generation as consultant for Gerteis Maschinen Prozessengineering AG Jari Ovaskainen– Main investor & chairman of the board Founded Iobox in 1999, sold for $250M in 2000
61. A multitude of further client projects are available and achievable (production capacity for a further 8-10 projects)
62. Atacama seeks bridge funding of 2.85 m€ to secure initial deals (via test developments), broaden platform (high containment) and to cover operational costs